Filtros de búsqueda

Lista de obras de

A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer

artículo científico publicado en 2019

Acquired resistance to endocrine treatments is associated with tumor-specific molecular changes in patient-derived luminal breast cancer xenografts.

artículo científico publicado en 2014

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers

artículo científico publicado en 2020

Capecitabine efficacy is correlated with TYMP and RB expression in PDX established from triple-negative breast cancers.

artículo científico publicado en 2018

Improvement of the anti-proliferative activity of the peptide ERα17p in MCF-7 breast cancer cells using nanodiamonds

artículo científico publicado en 2019

Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2-mutated breast cancer in combination to PARP inhibition

artículo científico publicado en 2018

Interaction between IGF2-PI3K axis and cancer-associated-fibroblasts promotes anal squamous carcinogenesis

artículo científico publicado en 2019

Metabolic Response to Everolimus in Patient-Derived Triple-Negative Breast Cancer Xenografts.

artículo científico publicado en 2017

PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma

artículo científico publicado en 2019

Selumetinib-based therapy in uveal melanoma patient-derived xenografts.

artículo científico publicado en 2018

Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers.

scientific article published on 21 June 2016

Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers.

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda